Isogenica

Isogenica | The VHH Company™ We specialise in the fast, customised discovery of VHH antibodies - small-format, single-domain binders engineered to accelerate development and de-risk the early stages of biologics R&D. Our proprietary CIS Display™ platform, paired with the world’s largest synthetic VHH libraries, enables more screening than traditional methods. The result: high-affinity, high-specificity candidates with the developability data biotech teams need to move faster and start stronger. From high-throughput screening to tailored VHH engineering, Isogenica delivers more than binders: we deliver scientific confidence, strengthened IP positions, and a clear path to milestones. We work as a true extension of your team - open, agile, and grounded in the trusted Cambridge UK biotech ecosystem. With over 25 years of experience and multiple clinical-stage programmes, we’re proud to be the discovery partner of choice for emerging biotechs and pharma leaders alike. Precision. Partnership. Progress. That’s the Isogenica difference. Start your discovery with us.